Security record · archived quarter
PBH
Prestige Consumer Healthcare Inc. · Healthcare · Medical - Pharmaceuticals
13Tracked holders
n/aΔ holders
3.54MShares held
$243.72MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | -6 | 34.03M | $1.61B | +5 | −12 |
| Q1 2026 | 110 | -5 | 35.15M | $2.08B | +6 | −12 |
| Q4 2025 | 116 | -2 | 39.06M | $2.41B | +1 | −2 |
| Q3 2025 | 19 | +1 | 21.74M | $1.36B | +2 | −2 |
| Q2 2025 | 16 | 0 | 19.92M | $1.59B | +1 | −1 |
| Q1 2025 | 13 | 0 | 5.41M | $464.71M | n/a | n/a |
| Q4 2024 | 13 | -1 | 5.31M | $414.35M | n/a | −1 |
| Q3 2024 | 13 | 0 | 3.46M | $249.12M | +1 | −1 |
| Q2 2024 | 13 | n/a | 3.54M | $243.72M | n/a | n/a |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.28M | n/a | $87.86M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (passive) | 504.78K | n/a | $34.75M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 445.91K | n/a | $30.70M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Renaissance Technologies ✦ | 373.80K | n/a | $25.74M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 317.24K | n/a | $21.84M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 123.92K | n/a | $8.53M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 114.95K | n/a | $7.91M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 113.93K | n/a | $7.84M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 101.22K | n/a | $6.97M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 101.12K | n/a | $6.96M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 32.40K | n/a | $2.23M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Arrowstreet Capital ✦ | 24.10K | n/a | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 10.48K | n/a | $721,548 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 350 holders, 51.73M shares, $2.97B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API